2026-04-14T04:56:28Zhttps://recercat.cat/oai/request
oai:recercat.cat:10230/721182025-12-05T15:13:26Zcom_2072_6col_2072_452952
RECERCAT author Ramos, Rafel author Quesada, Miquel author Solanas, Pascual author Subirana Cachinero, Isaac author Sala, J. author Vila, J. author Masiá, R. author Cerezo, C. author Elosua Llanos, Roberto author Grau, M. author Cordón, Ferran author Juvinyà, Dolors author Fitó Colomer, Montserrat author Covas Planells, Maria Isabel author Clará Velasco, Alberto author Muñoz, Miguel Ángel author Marrugat de la Iglesia, Jaume author REGICOR Investigators 2025-12-05T15:13:26Z 2025-12-05T15:13:26Z 2025-12-03T15:11:42Z2025-12-03T15:11:42Z20092025-12-03T15:11:42Z http://hdl.handle.net/10230/72118 Objectives: To determine the prevalence of ankle-brachial index (ABI)<0.9 and symptomatic peripheral arterial disease (PAD), association with cardiovascular risk factors (CVRF), and impact of adding ABI measurement to coronary heart disease (CHD) risk screening. Design: Population-based cross-sectional survey of 6262 participants aged 35-79 in Girona, Spain. Methods: Standardized measurements (CVRF, ABI, 10-year CHD risk) and history of intermittent claudication (IC), CHD, and stroke were recorded. ABI<0.9 was considered equivalent to moderate-to-high CHD risk (> or =10%). Results: ABI<0.9 prevalence was 4.5%. Only 0.62% presented low ABI and IC. Age, current smoker, cardiovascular disease, and uncontrolled hypertension independently associated with ABI<0.9 in both sexes; IC was also associated in men and diabetes in women. Among participants 35-74 free of cardiovascular disease, 6.1% showed moderate-to-high 10-year CHD risk; adding ABI measurement yielded 8.7%. Conversely, the risk function identified 16.8% of these participants as having 10-year CHD risk>10%. In participants 75-79 free of cardiovascular disease, the prevalence of ABI<0.9 (i.e., CHD risk> or =10%) was 11.9%. Conclusions: ABI<0.9 is relatively frequent in those 35-79, particularly over 74. However, IC and CHD risk> or =10% indicators are often missing. Adding ABI measurement to CHD-risk screening better identifies moderate-to-high cardiovascular risk patients. © Elsevier http://dx.doi.org/10.1016/j.ejvs.2009.04.013 info:eu-repo/semantics/openAccess Peripheral vasculardiseases Risk assessment Primary prevention Risk factors Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk info:eu-repo/semantics/article info:eu-repo/semantics/acceptedVersion